Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China · Delayed Price · Currency is CNY 26.03
-0.50 (-1.88%)
At close: Feb 12, 2026
SHE:003020 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 162.56 | 160.6 | 226.67 | 209.25 | 172.23 | 135.12 |
Depreciation & Amortization | 83.15 | 83.15 | 45.05 | 36.04 | 36.92 | 15.95 |
Other Amortization | 3.34 | 3.34 | 2.29 | 2.18 | 1.57 | 0.2 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | - | 2.54 | 0.03 | 0.03 |
Asset Writedown & Restructuring Costs | 6.43 | 6.43 | 0.12 | 0.39 | 3.2 | 1.49 |
Loss (Gain) From Sale of Investments | -13 | -13 | -28.16 | -34.9 | -11.22 | - |
Provision & Write-off of Bad Debts | 3.05 | 3.05 | 3.19 | 0.43 | - | - |
Other Operating Activities | 64.3 | 4.92 | 16.44 | 4.07 | 1.54 | 0.73 |
Change in Accounts Receivable | -133.76 | -133.76 | -211.49 | -94.2 | -29.57 | -37.62 |
Change in Inventory | 13.55 | 13.55 | -39.49 | -177.1 | 1.98 | -15.76 |
Change in Accounts Payable | 68.92 | 68.92 | 175.7 | 253.59 | -15.47 | 71.37 |
Change in Other Net Operating Assets | 3.24 | 3.24 | 10.07 | -0.3 | - | 0 |
Operating Cash Flow | 258.88 | 197.53 | 203.67 | 200.64 | 158.7 | 172.49 |
Operating Cash Flow Growth | -3.54% | -3.02% | 1.51% | 26.42% | -7.99% | 15.53% |
Capital Expenditures | -137.47 | -154.49 | -197.54 | -246.43 | -186.95 | -56.2 |
Sale of Property, Plant & Equipment | 2.19 | 0.49 | 0.12 | 0.33 | 0.27 | 0.01 |
Cash Acquisitions | - | -24.48 | -183.53 | - | - | - |
Divestitures | - | - | -25.15 | - | - | - |
Investment in Securities | 85.28 | -9.65 | -36 | 6.9 | -5.2 | - |
Other Investing Activities | 23.09 | 5.89 | 125.75 | 37.39 | - | - |
Investing Cash Flow | -26.92 | -182.23 | -314.85 | -201.8 | -191.88 | -56.19 |
Long-Term Debt Issued | - | 28.6 | 41.99 | - | - | - |
Total Debt Issued | - | 28.6 | 41.99 | - | - | - |
Short-Term Debt Repaid | - | -0.05 | - | - | - | -24 |
Long-Term Debt Repaid | - | -7.56 | -10.12 | -10.21 | -12.18 | - |
Total Debt Repaid | -7.61 | -7.61 | -10.12 | -10.21 | -12.18 | -24 |
Net Debt Issued (Repaid) | -7.61 | 20.99 | 31.87 | -10.21 | -12.18 | -24 |
Issuance of Common Stock | - | - | 72.08 | 27.05 | - | 535.69 |
Repurchase of Common Stock | -2.95 | -2.95 | - | - | - | - |
Common Dividends Paid | -110.32 | -80.93 | -61.28 | -64.85 | -46.32 | -28.08 |
Other Financing Activities | -28.28 | -15.44 | -6.04 | 0.06 | - | -75.17 |
Financing Cash Flow | -149.16 | -78.33 | 36.63 | -47.95 | -58.5 | 408.44 |
Foreign Exchange Rate Adjustments | -0.01 | 0.01 | 0.04 | 0.4 | -0.18 | -0.49 |
Net Cash Flow | 82.79 | -63.03 | -74.51 | -48.71 | -91.85 | 524.26 |
Free Cash Flow | 121.41 | 43.05 | 6.14 | -45.79 | -28.24 | 116.29 |
Free Cash Flow Growth | 14.90% | 601.38% | - | - | - | 10.34% |
Free Cash Flow Margin | 8.24% | 2.83% | 0.32% | -1.77% | -1.24% | 6.14% |
Free Cash Flow Per Share | 0.64 | 0.23 | 0.03 | -0.24 | -0.15 | 0.82 |
Cash Income Tax Paid | 144.4 | 171.81 | 149.94 | 151.93 | 116.23 | 108.61 |
Levered Free Cash Flow | -5.36 | -23.19 | 94.8 | -47.08 | -95.76 | 80.7 |
Unlevered Free Cash Flow | -4.06 | -21.99 | 95.61 | -46.52 | -94.91 | 80.86 |
Change in Working Capital | -50.93 | -50.93 | -61.94 | -19.35 | -45.55 | 18.96 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.